LBP-040 Long-term Efficacy and Safety of Open-Label Seladelpar Treatment in Patients with Primary Biliary Cholangitis (PBC): Interimresults for 2 Years from the ASSURE Study Palak Trivedi , Cynthia Levy , Kris V. Kowdley , Stuart C. Gordon , Christopher L. Bowlus , María‐Carlota Londoño , Gideon Hirschfield , Aliya Gulamhusein , Eric Lawitz , Alejandra Villamil , Alma Laura Ladrón de Guevara , Marlyn J. Mayo , Ziad Younes , Oren Shibolet , Kidist Yimam , D. K. Pratt , Jeong Heo , Ulrike Morgera , Pietro Andreoné , Andreas E. Kremer , Christophe Corpechot , Aparna Goel , Adam Peyton , Hany Elbeshbeshy , Daria B. Crittenden , Carrie L. Heusner , Sarah Proehl , Shu Zhou , Charles A. McWherter Journal of hepatology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
